Saxenda Compound peptide Pen - 6mg - 3ml
Weight Management • Appetite Control • Metabolic Support
Saxenda Compound Peptide Pen
Product Overview The Saxenda Compound Peptide Pen provides a high-quality, compounded alternative to brand-name weight management therapies. Each prefilled pen contains 6mg of Liraglutide in a 3ml solution, offering a concentration of 2mg/ml. Designed as a daily injectable treatment, this pen helps adults with obesity or overweight conditions manage their weight effectively when combined with a reduced-calorie diet and increased physical activity.
Key Benefits – Saxenda Compound Peptide Pen
- GLP-1 receptor agonist compound commonly researched for appetite and metabolic support
- May assist with appetite regulation and reduced food cravings
- Frequently researched for weight management and wellness-focused protocols
- Potential support for portion control and satiety-related studies
- Long-acting peptide profile designed for sustained activity throughout the day
- Convenient peptide pen format for precision handling and administration protocols
- High-quality compounded formulation designed for consistency and stability
- Suitable for advanced laboratory and metabolic research applications.
Disclaimer
This product is intended strictly for laboratory research purposes only. It is not a medicine and has not been evaluated or approved by the South African Health Products Regulatory Authority (SAHPRA) for human or animal use.
Not for human consumption or medical use. Products sold on this website are not intended to diagnose, treat, cure, or prevent any disease. By purchasing, the customer confirms they are qualified to handle and use this product in accordance with applicable laws and regulations.
